Cioato Stefania Giotti, Medeiros Liciane Fernandes, Marques Filho Paulo Ricardo, Vercelino Rafael, de Souza Andressa, Scarabelot Vanessa Leal, de Oliveira Carla, Adachi Lauren Naomi Spezia, Fregni Felipe, Caumo Wolnei, Torres Iraci L S
Graduate Program in Medicine - Medical Sciences, Universidade Federal do Rio Grande do Sul, 90035-003 Porto Alegre, Brazil; Laboratory of Pharmacology of Pain and Neuromodulation - Animal Models, Department of Pharmacology, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, 90050-170 Porto Alegre, Brazil; Animal Experimentation Unit, Graduate Research Group, Hospital de Clínicas de Porto Alegre, 90035-003 Porto Alegre, Brazil.
Laboratory of Pharmacology of Pain and Neuromodulation - Animal Models, Department of Pharmacology, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, 90050-170 Porto Alegre, Brazil; Animal Experimentation Unit, Graduate Research Group, Hospital de Clínicas de Porto Alegre, 90035-003 Porto Alegre, Brazil.
Brain Stimul. 2016 Mar-Apr;9(2):209-17. doi: 10.1016/j.brs.2015.12.001. Epub 2015 Dec 15.
Neuropathic pain (NP) is caused by an insult or dysfunction in the peripheral or central nervous system (CNS), the main symptoms being mechanical allodynia and hyperalgesia. NP often shows insufficient response to classic analgesics and its management remains a challenge. Transcranial direct current stimulation (tDCS) is a non-invasive method of cerebral stimulation and represents a promising resource for pain management.
OBJECTIVE/HYPOTHESIS: We investigated the effects of tDCS on the nociceptive response and on IL-1β, IL-10, and TNF-α levels in CNS structures of rats with NP.
After induction of NP by chronic constriction injury (CCI) of the sciatic nerve, the rats received 20 min of bicephalic tDCS for 8 days. Hyperalgesia was assessed by the hot plate and von Frey tests and evaluated at baseline, 7 days, and 14 days after CCI surgery, and also immediately, 24 hours, and 7 days following tDCS treatment. The levels of IL-1β, IL-10 and TNF-α in the cortex, spinal cord, and brainstem were determined by ELISA at 48 hours and 7 days post-tDCS.
The CCI model provoked thermal and mechanical hyperalgesia until at least 30 days post-CCI; however, bicephalic tDCS relieved the nociceptive behavior for up to 7 days after treatment completion.
Bicephalic tDCS is effective to promote antinociceptive behavior in neuropathic pain, which can be reflected by a spinal neuroimmunomodulation linked to pro- and anti-inflammatory cytokine levels observed in the long-term.
神经性疼痛(NP)由外周或中枢神经系统(CNS)损伤或功能障碍引起,主要症状为机械性异常性疼痛和痛觉过敏。NP对经典镇痛药常常反应不足,其治疗仍是一项挑战。经颅直流电刺激(tDCS)是一种非侵入性脑刺激方法,是疼痛治疗的一种有前景的手段。
目的/假设:我们研究了tDCS对NP大鼠中枢神经系统结构中伤害性反应以及白细胞介素-1β(IL-1β)、白细胞介素-10(IL-10)和肿瘤坏死因子-α(TNF-α)水平的影响。
通过坐骨神经慢性压迫损伤(CCI)诱导NP后,大鼠接受双侧tDCS 20分钟,共8天。通过热板试验和von Frey试验评估痛觉过敏,并在CCI手术后基线、7天和14天以及tDCS治疗后即刻、24小时和7天进行评估。在tDCS后48小时和7天,通过酶联免疫吸附测定法(ELISA)测定皮质、脊髓和脑干中IL-1β、IL-10和TNF-α的水平。
CCI模型诱发了热痛觉过敏和机械性痛觉过敏,至少持续到CCI后30天;然而,双侧tDCS在治疗完成后长达7天缓解了伤害性反应行为。
双侧tDCS可有效促进神经性疼痛中的抗伤害性行为,这可通过与长期观察到的促炎和抗炎细胞因子水平相关的脊髓神经免疫调节来体现。